Made-In-India Biological E Vaccine May Be 90% Effective

New Delhi: Biological E’s made-in-India vaccine is expected to have 90 per cent effectiveness against Covid, says a top doctor on a government advisory panel.

NK Arora, chairperson of the Centre’s Covid Working Group, has said that the vaccine is entering Phase 3 trials and could be available by October.

Dr Arora said Biological E’s vaccine – to be called Corbevax — is similar to the Novavax vaccine, which is more than 90 per cent effective including against Covid variants, according to the company.

Leave A Reply

Your email address will not be published.